rolipram has been researched along with Coronary Artery Disease in 1 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usta, C | 1 |
| Puddu, PE | 1 |
| Papalia, U | 1 |
| De Santis, V | 1 |
| Vitale, D | 1 |
| Tritapepe, L | 1 |
| Mazzesi, G | 1 |
| Miraldi, F | 1 |
| Ozdem, SS | 1 |
1 other study available for rolipram and Coronary Artery Disease
| Article | Year |
|---|---|
Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Dobutamine; Dose-Response Relationship, Dr | 2004 |